-
1 Comment
Progyny, Inc is currently in a long term uptrend where the price is trading 35.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.1.
Progyny, Inc's total revenue rose by 54.0% to $100M since the same quarter in the previous year.
Its net income has increased by 983.2% to $39M since the same quarter in the previous year.
Finally, its free cash flow grew by 182.9% to $6M since the same quarter in the previous year.
Based on the above factors, Progyny, Inc gets an overall score of 5/5.
Industry | Healthcare Plans |
---|---|
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US74340E1038 |
Sector | Healthcare |
Beta | 1.33 |
---|---|
PE Ratio | 40.18 |
Target Price | 26.75 |
Market Cap | 2B |
Dividend Yield | None |
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PGNY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025